GlassScriptPhysician profile
Adrian W Jachens
NPI 1063673408
$17,957.53
in general payments reported to CMS, 2019-2025
34 companies · $2,266 in 2025
The $2,266 reported for 2025 was more than what 89% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,410 · 2020: $394 · 2021: $1,026 · 2022: $2,340 · 2023: $4,056 · 2024: $4,465 · 2025: $2,266.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,769 · Honoraria: $2,000 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,769.18 |
| Honoraria | $2,000.00 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| New World Medical,INC. | $3,074.34 | 2022-2025 | Streamline, Ahmed Glaucoma Valve, Kahook Dual Blade |
| Johnson & Johnson Surgical Vision, INC. | $2,630.39 | 2019-2024 | Tecnis Iol, Tecnis Iol, Tecnis Simplicity |
| Glaukos Corporation | $2,499.32 | 2019-2025 | Idose, Idosetr |
| Lumenis Be INC | $1,800.00 | 2024 | M22 |
| Biotissue Holdings INC. | $1,619.23 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $1,306.91 | 2019-2025 | Cequa |
| Bausch & Lomb Americas INC. | $1,115.82 | 2022-2025 | Envista Mx60 Iol, Toric, Miebo |
| Harrow Eye, LLC | $542.92 | 2024-2025 | Vevye |
| Eyevance Pharmaceuticals LLC | $450.65 | 2019-2023 | Tobradex St |
| Oyster Point Pharma, INC. | $326.42 | 2022-2025 | Tyrvaya |
| Dompe US, INC. | $287.10 | 2022-2025 | Oxervate |
| Sight Sciences, INC. | $282.84 | 2021-2025 | Omni Surgical System, Sion Surgical Instrument |
| Mallinckrodt Hospital Products INC. | $249.93 | 2021-2025 | Acthar |
| Abbvie INC. | $227.56 | 2022-2025 | |
| Journey Medical Corporation | $227.25 | 2019-2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $212.98 | 2019-2025 | Tryptyr, Clareon, Eysuvis |
| Ivantis, INC | $203.37 | 2019-2021 | |
| Aerie Pharmaceuticals, INC. | $153.96 | 2019-2021 | |
| Ocular Therapeutix, INC. | $139.61 | 2022 | |
| Janssen Biotech, INC. | $105.45 | 2023-2025 | Tremfya, Simponi Aria, Simponi |
| Tarsus Pharmaceuticals, INC. | $89.16 | 2024-2025 | Xdemvy |
| Shire North American Group INC | $70.04 | 2019 | |
| Allergan, INC. | $68.74 | 2019-2021 | |
| Amgen INC. | $65.94 | 2025 | Tepezza |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $31.05 | 2023-2024 | Arazlo, Jublia, Cabtreo |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $29.67 | 2021 | |
| Coopervision INC. | $27.08 | 2022 | |
| Johnson & Johnson Vision Care, INC. | $20.09 | 2021 | |
| Rayner Intraocular Lenses Limited | $18.69 | 2023 | Rayone Emv, Omidria, Rayone Aspheric |
| Ucb, INC. | $17.58 | 2025 | Bimzelx |
| Lilly USA, LLC | $16.84 | 2024 | Olumiant |
| Kala Pharmaceuticals, INC. | $16.30 | 2021 | |
| Tearlab Corp | $15.79 | 2022 | |
| Mallinckrodt Enterprises LLC | $14.51 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adrian Jachens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.